| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.56M | 38.23M | 38.32M | 45.84M | 34.42M | 31.41M |
| Gross Profit | 12.53M | 13.24M | 10.34M | 13.87M | 11.40M | 9.77M |
| EBITDA | 9.95M | 5.52M | 5.86M | 9.48M | 8.08M | 6.64M |
| Net Income | 4.70M | 3.04M | 2.78M | 7.02M | 3.45M | 2.98M |
Balance Sheet | ||||||
| Total Assets | 58.35M | 59.97M | 55.47M | 51.59M | 39.55M | 35.09M |
| Cash, Cash Equivalents and Short-Term Investments | 9.87M | 10.03M | 7.71M | 6.82M | 6.74M | 4.47M |
| Total Debt | 7.64M | 10.81M | 10.04M | 9.14M | 4.88M | 6.45M |
| Total Liabilities | 15.36M | 18.60M | 17.20M | 16.35M | 11.85M | 11.32M |
| Stockholders Equity | 38.97M | 38.03M | 35.20M | 32.63M | 25.10M | 21.21M |
Cash Flow | ||||||
| Free Cash Flow | -2.35M | 603.61K | 2.00M | -504.40K | 3.75M | 4.63M |
| Operating Cash Flow | 3.05M | 5.57M | 6.99M | 1.48M | 4.54M | 5.71M |
| Investing Cash Flow | -2.37M | -2.45M | -5.67M | -2.22M | -659.54K | -3.22M |
| Financing Cash Flow | -3.08M | -978.33K | -437.95K | 848.33K | -1.71M | -2.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $177.48M | 22.49 | 5.32% | ― | -16.59% | -47.02% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $87.45M | 46.63 | 5.08% | ― | 0.18% | -54.25% | |
54 Neutral | $189.49M | -3.74 | -20.64% | ― | -8.00% | -35.86% | |
47 Neutral | $44.20M | -3.65 | ― | ― | 11013.00% | 39.85% | |
44 Neutral | $74.04M | 4,338.89 | 0.02% | 1.29% | -0.97% | -99.67% | |
44 Neutral | $17.40M | -0.04 | ― | 8.00% | -11.20% | 17.76% |
Flexible Solutions International announced its financial results for the third quarter of 2025, reporting a 13% increase in sales compared to the same period in 2024, with revenues reaching $10.56 million. Despite this growth, the company experienced a net loss of $503,358 due to higher costs and significant expenses related to new production contracts and equipment installations in Panama and Illinois. The company’s NanoChem division and ENP subsidiary remain key revenue sources, and new opportunities are emerging in various sectors, including food and nutrition supplements.